Literature DB >> 11705931

Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells.

W W Kum1, S B Cameron, R W Hung, S Kalyan, A W Chow.   

Abstract

The staphylococcal superantigen toxic shock syndrome toxin 1 (TSST-1) induces massive cytokine production, which is believed to be the key factor in the pathogenesis of TSS. The temporal sequence and kinetics of both proinflammatory and anti-inflammatory cytokines induced by TSST-1 in human peripheral blood mononuclear cells were investigated. A panel of loss-of-function single-amino-acid-substitution mutants of TSST-1, previously demonstrated to be defective in either major histocompatibility complex (MHC) class II binding (G31R) or T-cell receptor (TCR) interaction (H135A, S14N), was studied in parallel to further elucidate the mechanisms of cytokine secretion. Wild-type recombinant (WT r) TSST-1 induced a biphasic pattern of cytokine secretion: an early phase with rapid release of proinflammatory cytokines (especially gamma interferon, interleukin-2 [IL-2], and tumor necrosis factor alpha [TNF-alpha]) within 3 to 4 h poststimulation, and a later phase with more gradual production of both proinflammatory (IL-1beta, IL-12, and TNF-beta) and anti-inflammatory (IL-6, IL-10) cytokines within 16 to 72 h poststimulation. G31R, which is defective in MHC class II binding, induced a cytokine profile similar to that of WT rTSST-1, except that secretion of the early-phase proinflammatory cytokines was delayed and production of IL-1beta and IL-12 was markedly reduced. In contrast, mutant toxins defective in TCR interaction either demonstrated complete absence of any cytokine secretion during the entire observation period (H135A) or resulted in complete abolishment of IL-2 and other early-phase proinflammatory cytokines, while secretion of IL-10 appeared unaffected (S14N). Neither WT rTSST-1 nor the mutant toxins induced IL-4 or transforming growth factor beta. Our data indicate that effective TCR interaction is critical for the induction of the early-phase proinflammatory cytokine response, thus underscoring the importance of T-cell signaling in TSS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705931      PMCID: PMC98845          DOI: 10.1128/IAI.69.12.7544-7549.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Induction of a cytokine network by superantigens with parallel TH1 and TH2 stimulation.

Authors:  L Rink; J Luhm; M Koester; H Kirchner
Journal:  J Interferon Cytokine Res       Date:  1996-01       Impact factor: 2.607

Review 2.  Immunoregulatory mechanisms of T-cell-dependent shock induced by a bacterial superantigen in mice.

Authors:  S Florquin; M Goldman
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

Review 3.  Functional diversity of helper T lymphocytes.

Authors:  A K Abbas; K M Murphy; A Sher
Journal:  Nature       Date:  1996-10-31       Impact factor: 49.962

4.  IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses.

Authors:  L Meyaard; E Hovenkamp; S A Otto; F Miedema
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

5.  Bacterial superantigen-induced human lymphocyte responses are nitric oxide dependent and mediated by IL-12 and IFN-gamma.

Authors:  S Sriskandan; T J Evans; J Cohen
Journal:  J Immunol       Date:  1996-04-01       Impact factor: 5.422

6.  Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.

Authors:  W W Kum; K B Laupland; A W Chow
Journal:  Can J Microbiol       Date:  2000-02       Impact factor: 2.419

7.  Development in vitro of human CD4+ thymocytes into functionally mature Th2 cells. Exogenous interleukin-12 is required for priming thymocytes to produce both Th1 cytokines and interleukin-10.

Authors:  M C Mingari; E Maggi; A Cambiaggi; F Annunziato; F Schiavetti; R Manetti; L Moretta; S Romagnani
Journal:  Eur J Immunol       Date:  1996-05       Impact factor: 5.532

8.  Biological activity of toxic shock syndrome toxin 1 and a site-directed mutant, H135A, in a lipopolysaccharide-potentiated mouse lethality model.

Authors:  B G Stiles; T Krakauer; P F Bonventre
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice.

Authors:  P Matthys; T Mitera; H Heremans; J Van Damme; A Billiau
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

10.  Inhibition of toxic shock syndrome toxin-1-induced cytokine production and T cell activation by interleukin-10, interleukin-4, and dexamethasone.

Authors:  T Krakauer
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

View more
  10 in total

1.  Effects of different branched-chain amino acids supplementation protocols on the inflammatory response of LPS-stimulated RAW 264.7 macrophages.

Authors:  Andrea Bonvini; Marcelo Macedo Rogero; Audrey Yule Coqueiro; Raquel Raizel; Leonardo Mendes Bella; Ricardo Ambrosio Fock; Primavera Borelli; Julio Tirapegui
Journal:  Amino Acids       Date:  2021-03-14       Impact factor: 3.520

2.  Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology.

Authors:  Peter A Szabo; Ankur Goswami; Delfina M Mazzuca; Kyoungok Kim; David B O'Gorman; David A Hess; Ian D Welch; Howard A Young; Bhagirath Singh; John K McCormick; S M Mansour Haeryfar
Journal:  J Immunol       Date:  2017-02-20       Impact factor: 5.422

3.  Toxin profiling of Staphylococcus aureus strains involved in varicella superinfection.

Authors:  Olivia Raulin; Géraldine Durand; Yves Gillet; Michèle Bes; Gerard Lina; François Vandenesch; Daniel Floret; Jerome Etienne; Frédéric Laurent
Journal:  J Clin Microbiol       Date:  2010-03-19       Impact factor: 5.948

4.  Correlation of proinflammatory and anti-inflammatory cytokine levels with histopathological changes in an adult mouse lung model of Campylobacter jejuni infection.

Authors:  Nadia Al-Banna; Raj Raghupathy; M John Albert
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

5.  Superantigen-mediated differentiation of bovine monocytes into dendritic cells.

Authors:  Keun Seok Seo; Joo Youn Park; William C Davis; Lawrence K Fox; Mark A McGuire; Yong Ho Park; Gregory A Bohach
Journal:  J Leukoc Biol       Date:  2009-01-07       Impact factor: 4.962

6.  Staphylococcal superantigen (TSST-1) mutant analysis reveals that t cell activation is required for biological effects in the rabbit including the cytokine storm.

Authors:  Norbert Stich; Martina Waclavicek; Nina Model; Martha M Eibl
Journal:  Toxins (Basel)       Date:  2010-09-09       Impact factor: 4.546

7.  Innate immune responses following Kawasaki disease and toxic shock syndrome.

Authors:  Katherine Y H Chen; Nicole Messina; Susie Germano; Rhian Bonnici; Bridget Freyne; Michael Cheung; Greta Goldsmith; Tobias R Kollmann; Michael Levin; David Burgner; Nigel Curtis
Journal:  PLoS One       Date:  2018-02-15       Impact factor: 3.240

8.  Air particulate matter SRM 1648a primes macrophages to hyperinflammatory response after LPS stimulation.

Authors:  Anna Gawda; Grzegorz Majka; Bernadeta Nowak; Małgorzata Śróttek; Maria Walczewska; Janusz Marcinkiewicz
Journal:  Inflamm Res       Date:  2018-06-19       Impact factor: 4.575

9.  Staphylococcal toxic shock syndrome toxin-1 induces the translocation and secretion of high mobility group-1 protein from both activated T cells and monocytes.

Authors:  Shirin Kalyan; Anthony W Chow
Journal:  Mediators Inflamm       Date:  2008-11-04       Impact factor: 4.711

10.  Beta-(1-->3)-D-glucan modulates DNA binding of nuclear factors kappaB, AT and IL-6 leading to an anti-inflammatory shift of the IL-1beta/IL-1 receptor antagonist ratio.

Authors:  Juergen Luhm; Ulrich Langenkamp; Jenny Hensel; Christoph Frohn; Joerg M Brand; Holger Hennig; Lothar Rink; Petra Koritke; Nadine Wittkopf; David L Williams; Antje Mueller
Journal:  BMC Immunol       Date:  2006-03-22       Impact factor: 3.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.